# ClinicalTrials.gov record NCT01088529

> PeptideScanner retained ClinicalTrials.gov record NCT01088529 at 2026-07-30T21:54:46.544Z. Its registry update date was 2014-05-15, and PeptideScanner's reviewed identity mapping was leuprolide.

- Evidence object: `story:clinicaltrials-gov-nct01088529-leuprolide:v1`
- Evidence domain: Clinical trials
- Date in source: 2014-05-15
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct01088529-leuprolide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct01088529-leuprolide-v1.json
- Content SHA-256: `af1f3dc57a632c5a332fbccc637cbb6c542fe5e2c13dce21f9dd4ef24667af3b`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT01088529 ([`ctg-observation-nct01088529-2014-05-15-4b8b20b0f21c`](#source-ctg-observation-nct01088529-2014-05-15-4b8b20b0f21c))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT01088529 at 2026-07-30T21:54:46.544Z. Its registry update date was 2014-05-15, and PeptideScanner's reviewed identity mapping was leuprolide. ([`ctg-observation-nct01088529-2014-05-15-4b8b20b0f21c`](#source-ctg-observation-nct01088529-2014-05-15-4b8b20b0f21c))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT01088529 at 2026-07-30T21:54:46.544Z. Its registry update date was 2014-05-15, and PeptideScanner's reviewed identity mapping was leuprolide. ([`ctg-observation-nct01088529-2014-05-15-4b8b20b0f21c`](#source-ctg-observation-nct01088529-2014-05-15-4b8b20b0f21c))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct01088529-2014-05-15-4b8b20b0f21c`](#source-ctg-observation-nct01088529-2014-05-15-4b8b20b0f21c))

## Sources

<a id="source-ctg-observation-nct01088529-2014-05-15-4b8b20b0f21c"></a>
- **ClinicalTrials.gov record NCT01088529 · retained source version 2014-05-15:4b8b20b0f21cab674b1e7de600d7ffe58dc0a18fc6c24221d462f75891c4344b** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT01088529) (`ctg-observation-nct01088529-2014-05-15-4b8b20b0f21c`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT01088529." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct01088529-leuprolide-v1.json SHA-256: af1f3dc57a632c5a332fbccc637cbb6c542fe5e2c13dce21f9dd4ef24667af3b.